For citations:
Ermolaeva A.D., Ermolaeva T.N., Krysanova V.S., Kokushkin K.A. Pharmacoeconomic evaluation of triple beclomethasone/glycopyrronium bromide/formoterol combination in the treatment of patients with moderate and severe chronic obstructive pulmonary disease. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2026;19(2):234–243. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.389
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 